{"filing":{"accession_number":"0001104659-26-091691","cik":"0001372299","ticker":"OCGN","company_name":"Ocugen, Inc.","form":"8-K","filing_date":"2026-08-06","report_date":"2026-08-06","primary_document":"tm2622368d1_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1372299/000110465926091691/tm2622368d1_8k.htm"},"events":[{"id":25413,"run_id":23066,"accession_number":"0001104659-26-091691","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"Ocugen issued a press release on August 6, 2026, announcing second quarter 2026 financial results, including cash position ($100.4M as of June 30, 2026), operating expenses ($17.9M for Q2 2026), and net loss per share ($0.07). The filing explicitly states the Company \"reported second quarter 2026 financial results\" and includes condensed consolidated balance sheets and statements of operations. This is a standard quarterly earnings disclosure under Item 2.02.","company_name":"Ocugen, Inc.","ticker":"OCGN","filing_date":"2026-08-06","form":"8-K","submitted_at":null,"items":[{"id":26238,"accession_number":"0001104659-26-091691","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Ocugen issued a press release on August 6, 2026, announcing second quarter 2026 financial results, including cash position ($100.4M as of June 30, 2026), operating expenses ($17.9M for Q2 2026), and net loss per share ($0.07). The filing explicitly states the Company \"reported second quarter 2026 financial results\" and includes condensed consolidated balance sheets and statements of operations. This is a standard quarterly earnings disclosure under Item 2.02.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-08T02:40:00.427052+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":26238,"accession_number":"0001104659-26-091691","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Ocugen issued a press release on August 6, 2026, announcing second quarter 2026 financial results, including cash position ($100.4M as of June 30, 2026), operating expenses ($17.9M for Q2 2026), and net loss per share ($0.07). The filing explicitly states the Company \"reported second quarter 2026 financial results\" and includes condensed consolidated balance sheets and statements of operations. This is a standard quarterly earnings disclosure under Item 2.02.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-08T02:40:00.427052+00:00","company_name":"Ocugen, Inc.","ticker":"OCGN","filing_date":"2026-08-06"}]}